The pathophysiological changes in T2DM affecting bone metabolism are complex and dependent on many factors, including muscle-derived hormones, inflammatory cytokines, hydrogen sulfide, and incretin levels. The gene discussed is GCG; the disease is type 2 diabetes mellitus.